BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 30216655)

  • 1. A pan-cancer atlas of cancer hallmark-associated candidate driver lncRNAs.
    Deng Y; Luo S; Zhang X; Zou C; Yuan H; Liao G; Xu L; Deng C; Lan Y; Zhao T; Gao X; Xiao Y; Li X
    Mol Oncol; 2018 Nov; 12(11):1980-2005. PubMed ID: 30216655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive characterization of lncRNA-mRNA related ceRNA network across 12 major cancers.
    Zhang Y; Xu Y; Feng L; Li F; Sun Z; Wu T; Shi X; Li J; Li X
    Oncotarget; 2016 Sep; 7(39):64148-64167. PubMed ID: 27580177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of cancer hallmark-associated gene and lncRNA cooperative regulation pairs and dictate lncRNA roles in oral squamous cell carcinoma.
    Lin K; Song LJ; Ma J; Zhang TS; You DY; He YW
    J Cell Mol Med; 2020 May; 24(9):5213-5223. PubMed ID: 32202050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive functional profiling of long non-coding RNAs through a novel pan-cancer integration approach and modular analysis of their protein-coding gene association networks.
    Walters K; Sarsenov R; Too WS; Hare RK; Paterson IC; Lambert DW; Brown S; Bradford JR
    BMC Genomics; 2019 Jun; 20(1):454. PubMed ID: 31159744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and analysis of lncRNA-lncRNA synergistic networks to reveal clinically relevant lncRNAs in cancer.
    Li Y; Chen J; Zhang J; Wang Z; Shao T; Jiang C; Xu J; Li X
    Oncotarget; 2015 Sep; 6(28):25003-16. PubMed ID: 26305674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative CAGE and DNA Methylation Profiling Identify Epigenetically Regulated Genes in NSCLC.
    Horie M; Kaczkowski B; Ohshima M; Matsuzaki H; Noguchi S; Mikami Y; Lizio M; Itoh M; Kawaji H; Lassmann T; Carninci P; Hayashizaki Y; Forrest ARR; Takai D; Yamaguchi Y; Micke P; Saito A; Nagase T
    Mol Cancer Res; 2017 Oct; 15(10):1354-1365. PubMed ID: 28698358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of driver copy number alterations in diverse cancer types and application in drug repositioning.
    Zhou W; Zhao Z; Wang R; Han Y; Wang C; Yang F; Han Y; Liang H; Qi L; Wang C; Guo Z; Gu Y
    Mol Oncol; 2017 Oct; 11(10):1459-1474. PubMed ID: 28719033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative Genomic Analyses Identify LncRNA Regulatory Networks across Pediatric Leukemias and Solid Tumors.
    Modi A; Lopez G; Conkrite KL; Su C; Leung TC; Ramanan S; Manduchi E; Johnson ME; Cheung D; Gadd S; Zhang J; Smith MA; Guidry Auvil JM; Meshinchi S; Perlman EJ; Hunger SP; Maris JM; Wells AD; Grant SFA; Diskin SJ
    Cancer Res; 2023 Oct; 83(20):3462-3477. PubMed ID: 37584517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers.
    Yan X; Hu Z; Feng Y; Hu X; Yuan J; Zhao SD; Zhang Y; Yang L; Shan W; He Q; Fan L; Kandalaft LE; Tanyi JL; Li C; Yuan CX; Zhang D; Yuan H; Hua K; Lu Y; Katsaros D; Huang Q; Montone K; Fan Y; Coukos G; Boyd J; Sood AK; Rebbeck T; Mills GB; Dang CV; Zhang L
    Cancer Cell; 2015 Oct; 28(4):529-540. PubMed ID: 26461095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated analysis of long non-coding RNA‑associated ceRNA network reveals potential lncRNA biomarkers in human lung adenocarcinoma.
    Sui J; Li YH; Zhang YQ; Li CY; Shen X; Yao WZ; Peng H; Hong WW; Yin LH; Pu YP; Liang GY
    Int J Oncol; 2016 Nov; 49(5):2023-2036. PubMed ID: 27826625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and analysis of dysregulated lncRNA-associated ceRNA network identified novel lncRNA biomarkers for early diagnosis of human pancreatic cancer.
    Zhou M; Diao Z; Yue X; Chen Y; Zhao H; Cheng L; Sun J
    Oncotarget; 2016 Aug; 7(35):56383-56394. PubMed ID: 27487139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competing endogenous RNA networks and gastric cancer.
    Guo LL; Song CH; Wang P; Dai LP; Zhang JY; Wang KJ
    World J Gastroenterol; 2015 Nov; 21(41):11680-7. PubMed ID: 26556995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative analysis reveals the dosage sensitivity and regulatory patterns of lncRNA in prostate cancer.
    Liu Y; Zhang R; Zhao N; Zhang Q; Yan Z; Chang Z; Wei Y; Wu C; Xu J; Xu Y
    Mol Biosyst; 2016 Oct; 12(10):3176-85. PubMed ID: 27507663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma.
    Zhang Z; Qian W; Wang S; Ji D; Wang Q; Li J; Peng W; Gu J; Hu T; Ji B; Zhang Y; Wang S; Sun Y
    Cell Physiol Biochem; 2018; 49(5):1778-1791. PubMed ID: 30231249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma.
    Xing Y; Zhao Z; Zhu Y; Zhao L; Zhu A; Piao D
    Oncol Rep; 2018 May; 39(5):2365-2375. PubMed ID: 29565464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying Cancer Driver lncRNAs Bridged by Functional Effectors through Integrating Multi-omics Data in Human Cancers.
    Zhang Y; Liao G; Bai J; Zhang X; Xu L; Deng C; Yan M; Xie A; Luo T; Long Z; Xiao Y; Li X
    Mol Ther Nucleic Acids; 2019 Sep; 17():362-373. PubMed ID: 31302496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell Carcinoma.
    Song J; Peng J; Zhu C; Bai G; Liu Y; Zhu J; Liu J
    Cell Physiol Biochem; 2018; 48(6):2549-2562. PubMed ID: 30121668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated analysis of long non-coding RNA competing interactions reveals the potential role in progression of human gastric cancer.
    Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
    Int J Oncol; 2016 May; 48(5):1965-76. PubMed ID: 26935047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemically identifying and prioritizing risk lncRNAs through integration of pan-cancer phenotype associations.
    Xu C; Qi R; Ping Y; Li J; Zhao H; Wang L; Du MY; Xiao Y; Li X
    Oncotarget; 2017 Feb; 8(7):12041-12051. PubMed ID: 28076842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of cancer-related potential biomarkers based on lncRNA-pseudogene-mRNA competitive networks.
    Wu C; Wei Y; Zhu Y; Li K; Zhu Y; Zhao Y; Chang Z; Xu Y
    FEBS Lett; 2018 Mar; 592(6):973-986. PubMed ID: 29453881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.